Status:
UNKNOWN
PET/MRI Study on Changes of Fat and Muscle Metabolism.
Lead Sponsor:
Tang-Du Hospital
Conditions:
Brown Fat and Muscle Metabolic
Differential Diagnosis
Eligibility:
All Genders
15-50 years
Brief Summary
False positives for Brown Fat \& Muscle（F\&M） always affect the evaluation of metabolic disease treatment. Recently, using PET/CT，international journals such as Journal of Nuclear Medicine reported th...
Eligibility Criteria
Inclusion
- Clinical diagnosis of malignant tumor
- Have not yet been receiving comprehensive treatment and should begin within one month
- Fasting glucose of diabetic patients is controlled below 11.1 mmol/L.
- Inclusion Criteria for Healthy Control Participants:
- • Clinical diagnosis of Healthy Control
Exclusion
- Fasting glucose ≥11.1mmol/L
- History of endocrine disease (such as chronic glomerulonephritis, Addison's disease)
- Neurological signs and/or history of neurological disease
- Have begun comprehensive treatment
- Presence of magnetically active objects in the body
- Claustrophobia or any other medical condition that would preclude the participant from lying in the PET/MRI scanner for approximately 40 mins.
Key Trial Info
Start Date :
July 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
300 Patients enrolled
Trial Details
Trial ID
NCT04334720
Start Date
July 1 2019
End Date
August 1 2023
Last Update
April 6 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tangdu Hospital
Xi'an, Shaanxi, China, 710038